Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps

Written by: | admin@medadnews.com | Dated: Friday, January 19th, 2018

 

In Personalized Medicine and Value Assessment Frameworks: Context, Considerations, and Next Steps, PMC contends that most value assessment frameworks could unintentionally undermine the health care community’s push toward more personalized care.

The paper points out that most value assessment frameworks still make sweeping conclusions about the economic worth of a particular treatment based almost exclusively on population averages. As a result, the paper contends, most value assessment frameworks could unintentionally discourage payers and providers from considering important information about a patient’s biology, values and preferences that can improve health outcomes — especially when value assessment frameworks influence the coverage and payment decisions that determine whether patients have access to treatment options that will work for them.

 

To access the white paper, please click here

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!

Subscribe

Ad Right Bottom